American Vietnamese Biotech (HSTC:AMV) Change In Receivables : ₫0.00 Mil (TTM As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Change In Receivables?

American Vietnamese Biotech's change in receivables for the quarter that ended in . 20 was ₫0.00 Mil. It means American Vietnamese Biotech's Accounts Receivable stayed the same from . 20 to . 20 .

American Vietnamese Biotech's change in receivables for the fiscal year that ended in . 20 was ₫0.00 Mil. It means American Vietnamese Biotech's Accounts Receivable stayed the same from . 20 to . 20 .

American Vietnamese Biotech's Accounts Receivable for the quarter that ended in . 20 was ₫0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. American Vietnamese Biotech's liquidation value for the three months ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Change In Receivables Historical Data

The historical data trend for American Vietnamese Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Change In Receivables Chart

American Vietnamese Biotech Annual Data

Trend

Change In Receivables

American Vietnamese Biotech Quarterly Data

Change In Receivables

American Vietnamese Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.

American Vietnamese Biotech (HSTC:AMV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

American Vietnamese Biotech's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of liquidation value, American Vietnamese Biotech's accounts receivable are only considered to be worth 75% of book value:

American Vietnamese Biotech's liquidation value for the quarter that ended in . 20 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=		-		+	0.75 *	+	0.5 *
=	0.00

American Vietnamese Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.